Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Agnosia × Acetaminophen × Clear all

Phase

Phase 4 4 Phase NA 1 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 5 Neoplasms 2 Multiple Myeloma 2 Cancer Pain 2 Squamous Cell Carcinoma of Head and Neck 1 Pain, Postoperative 1 Paget Disease, Extramammary 1 Ovarian Neoplasms 1 Lymphoma 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1 Agnosia 1

Interventions

Ketamine 3 Sodium Chloride 2 Ropivacaine 2 Propofol 2 Analgesics, Opioid 2 Analgesia, Patient-Controlled 2 parecoxib 1 Tea 1 Tapentadol 1 Surveys and Questionnaires 1 Sevoflurane 1 Saline Solution 1 Lidocaine 1 Ketorolac 1 Ibuprofen 1 Epinephrine 1 Dexamethasone 1 Codeine 1 Clonidine 1 Circumcision, Male 1 Celecoxib 1 Anesthesia, General 1 Acupuncture Therapy 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡